{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["32(9)"],"submitter":["Obermannova R"],"journal":["Annals of oncology : official journal of the European Society for Medical Oncology"],"pagination":["S1131-S1131"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8454423"],"repository":["biostudies-literature"],"pubmed_title":["1563MO CoVigi phase IV multicentric trial evaluating COVID-19 vaccination adverse events and immune response dynamics in cancer patients: First results on antibody and cellular immunity"],"pmcid":["PMC8454423"],"pubmed_authors":["Mlnarikova M","Mayer J","Nevrlka J","Demlova R","Valik D","Zdrazilova-Dubska L","Weinbergerova B","Okrouhlicova D","Selingerova I","Obermannova R","Doubek M","Cermakova Z","Pilatova K","Lejdarova H","Kiss I"],"additional_accession":[]},"is_claimable":false,"name":"1563MO CoVigi phase IV multicentric trial evaluating COVID-19 vaccination adverse events and immune response dynamics in cancer patients: First results on antibody and cellular immunity","description":null,"dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Sep","modification":"2025-04-19T10:33:55.004Z","creation":"2022-02-11T11:17:11.47Z"},"accession":"S-EPMC8454423","cross_references":{}}